MYX 1.51% $4.71 mayne pharma group limited

Ann: 2022 Full Year Media Release, page-12

  1. 1,361 Posts.
    lightbulb Created with Sketch. 253
    A few more years relying on our big ticket products that need to do exceptionally well given what they cost us and hopefully go on developing / buying commercializing new products praying they'll do well enough to interest some entity will take us over . So much for company's growth which cost early shareholders dearly in both monetary and years waiting in vain hoping to see company post a net profit that never happened . Now Mayne's unsustainable growth in the US now sold and proceeds used to pay down out of control debt and hair brained decision to squander a good part of it on some special dividend which will amount to almost nothing considering the number of holders on board now a penny stock . Well done board .
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.71
Change
0.070(1.51%)
Mkt cap ! $400.7M
Open High Low Value Volume
$4.67 $4.75 $4.62 $953.1K 203.6K

Buyers (Bids)

No. Vol. Price($)
1 1236 $4.71
 

Sellers (Offers)

Price($) Vol. No.
$4.72 620 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.